[Intravenous immunoglobulins and autoimmune thrombopenic purpura].

OBJECTIVE

To determine the usefulness of intravenous immunoglobulin in the treatment of autoimmune thrombocytopenic purpura (AITP).

RESULTS

IVIg infusion is an important agent in managing AITP because most patients experienced a rapid increased platelet count. Its precise place in the management of these patients is however controversial, particularly on account of its high cost and transient effect. It is indicated in the severe form of the disease or before surgery in corticoresistant patients.

PERSPECTIVE

Prospective studied are mandatory to compare the efficacy of IVIg and high dose corticosteroids in this indication.